Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Multicomponent azide–alkyne cycloaddition catalyzed by impregnated bimetallic nickel and copper on magnetite

Juana M. Pérez , Rafael Cano and Diego J. Ramón *
Instituto de Síntesis Orgánica (ISO), and Departamento de Química Orgánica, Facultad de Ciencias, Universidad de Alicante, Apdo. 99, E-03080-Alicante, Spain. E-mail: djramon@ua.es; Fax: +35-965903549; Tel: +35-965903548

Received 8th April 2014 , Accepted 21st May 2014

First published on 21st May 2014


Abstract

A new bimetallic catalyst derived from nickel and copper has been used successfully for the first time in the multicomponent reaction of terminal alkynes, sodium azide, and benzyl bromide derivatives. The presence of both metallic species on the surface of magnetite seems to have a positive and synergetic effect. The catalyst loading is the lowest ever published for a catalyst of copper anchored on any type of iron support. The catalyst could be easily removed from the reaction media just by magnetic decantation and it could be reused up to ten times without any negative effect on the initial results.


Introduction

Although the 1,3-dipolar cycloaddition of azide derivatives and alkynes dates back to the nineteenth century,1 the pioneer and seminal works of the Medal2 and Sharpless3 groups on the copper-catalyzed process were the definitive push for the blossoming of this process. This process allowed access to different 1,2,3-triazoles of great interest to different areas of chemistry and pharmacy, in short reaction times, under mild conditions, and as only one regioisomer.4

The tremendous success of the homogenous copper(I) complexes as catalysts has eclipsed the activity of others, such as those derived from ruthenium, platinum, palladium,5 silver6 or nickel,7 as well as the use of other heterogeneous catalysts. However, very recently some heterogeneous catalysts have emerged as an alternative. Thus, the particles of copper,8 or its oxide derivatives,9 different copper salts supported on charcoal,10 on organic materials,11 as well as on inorganic supports12 have been tested for this transformation, with copper loading of these catalysts ranging from 0.5 to 12 mol%. Interestingly, some of the inorganic supports were based on iron, which permitted the development of magnetic catalyst and separation, as it was for the case of copper supported on iron (5 mol%),13 copperferrite (5 mol%),14 or ligand-grafted copper on magnetite (2 mol%).15

The intrinsic instability of organic azides, mainly those of low molecular weight, has been an important drawback in the generalization of this approach for the synthesis of interesting polyvalent structures. However, the use of a multicomponent approach, generating the azide derivative in situ by reaction of sodium azide and the corresponding organic reagent,9c,10b,d–f,11d,f,h,12f,h,14,15b,16 has permitted us to overcome this problem. On the other hand, we have recently developed a new, simple and robust method to immobilize different metal oxides17 onto magnetite,18 and we initially decided to apply the copper impregnated on magnetite catalyst19 to the multicomponent azide–alkyne cycloaddition reaction.

Results and discussion

Simple azide–alkyne cycloaddition

Although our ultimate goal was to get a heterogeneous and recyclable catalyst for the multicomponent version of azide–alkyne cycloaddition, the study was started with the standard two-component reaction between ethynylbenzene (1a) and (azidomethyl)benzene (2a) catalyzed by impregnated copper on magnetite (Table 1).
Table 1 Optimization of cycloaddition reaction conditions

image file: c4ra03149k-u1.tif

Entry Solvent T (°C) t (d) Yielda3a (4a) (%)
a Isolated yield after column chromatography. b Reaction carried out in absence of catalyst. c Reaction performed using only nanomagnetite (21 mol%).
1b H2O 110 7 46 (49)
2 PhMe 70 2 58 (0)
3 PhMe 25 2 35 (7)
4 PhMe 110 2 73 (25)
5 THF 70 2 43 (7)
6 CHCl3 70 2 52 (6)
7 MeCN 70 2 15 (6)
8 DMSO 70 2 33 (8)
9 MeOH 70 2 50 (0)
10 H2O 70 1 94 (0)
11   70 2 73 (12)
12c H2O 70 1 82 (1)


The initial reaction was conducted in absence of catalyst at 110 °C in water, obtaining after 7 days a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 mixture of both possible isomers. Then, the reaction was repeated in the presence of copper catalyst in toluene at 70 °C giving exclusively 1-benzyl-4-phenyl-1H-1,2,3-triazole (3a) in a modest yield (entry 2). Both the decrease and the increase of temperature led to the formation of a mixture of regioisomers (entries 3 and 4). Then, the influence of solvent was examined, finding that the highest yield was reached in water (entry 10). Under these conditions, the role of magnetite support was studied and high activity of the supposed inert material was found (entry 12).

Once the activity of copper catalyst was examined, its recycling was studied. After the first trial, the magnetite was collected with a magnet, washed with toluene and ethanol, and dried. The recycled catalyst could be re-used three fold with similar results (82–78%). However, the yield dropped to 35% in the forth use, keeping this level of results during the following 5 cycles (Fig. 1). The phenomenon of leaching was studied by ICP-MS analysis of the resulting reaction solution mixture, and 1.1% of the initial amount of copper was detected (0.007% of iron), which could explained the lost of activity. Moreover, the TEM images of the recycled catalyst showed a small change in copper particle size from 7.1 ± 6.5 nm of the fresh prepared catalyst to 6.4 ± 5.2 nm for the recycled one, which would not affect the reactivity of the recycled catalyst. Finally, it should be pointed out that the BET surface area did not suffer a great change, from 6.2 m2 g−1 for the initial catalyst to 8.4 m2 g−1 for the used one, which is practically the same specific area.


image file: c4ra03149k-f1.tif
Fig. 1 Recycling of CuO–Fe3O4 catalyst for the cycloaddition.

Multicomponent cycloaddition processes

After finding that copper catalyst was effective in the cycloaddition between azides and terminal alkynes, we faced the problem of the multicomponent version,9c,10d,e,11d,h,12h,14,15b,16b,c using benzyl bromide (5a), sodium azide (6) and ethynylbenzene (1a) as reaction model (Table 2). The reaction in water gave a mixture of expected heterocycle 3a together with its regioisomer 4a (compare entry 1 in Table 2 and entry 9 in Table 1). This initial trial showed that the change from simple cycloaddition to the multicomponent reaction one was not so simple. Thus, a new optimization process on this multicomponent reaction was carried out, starting by studying the effect of solvent (entries 1–8 in Table 2). The best result was obtained in absence of solvent, but a small amount of the product arising from homocoupling of terminal alkyne was found.19e The optimal temperature seemed to be 50 °C (entries 8–11), since at higher temperatures different by-products were formed, and at lower temperatures a modest yield was achieved. Finally, the increase of amount of reagents, 5a and 6, increased the yield (compare entry 12 in Table 2 with entry 9 in Table 1).
Table 2 Optimization of multicomponent cycloaddition process

image file: c4ra03149k-u2.tif

Entry Solvent T (°C) t (d) Yielda3a (4a) (%)
a Isolated yield after column chromatography. b 1,4-Diphenylbuta-1,3-diyne was isolated in a 10%. c Reaction performed using 2 equiv. of compounds 5a and 6.
1 H2O 70 3 57 (13)
2 PhMe 70 3 33 (0)
3 THF 70 3 21 (4)
4 CHCl3 70 3 19 (1)
5 MeCN 70 3 16 (0)
6 DMSO 70 3 25 (3)
7 MeOH 70 3 32 (25)
8 70 3 69b (0)
9 50 2 71 (0)
10 25 3 38 (0)
11 110 2 53b (6)
12c 25 2 83 (0)


Although copper catalysts have been the most used, other metal catalysts have also shown some activity for this reaction. For this reason we tested a series of impregnated metal catalyst in this multicomponent version (Table 3), starting from the uncatalyzed reaction (entry 1). From all ductile metal oxide, only nickel and copper catalysts showed activity (entries 2–14).

Table 3 Optimization of catalyst for multicomponent cycloaddition

image file: c4ra03149k-u3.tif

Entry Catalyst (mol%) Yielda3a (%)
a Isolated yield after column chromatography. b Powder < 5 μm. c Powder < 50 nm. d Reaction performed during 24 h.
1 0
2 Fe3O4b (21) 0
3 Fe3O4c (21) 0
4 CoO–Fe3O4 (1.4) 0
5 NiO–Fe3O4 (1.0) 5
6 CuO–Fe3O4 (0.9) 83
7 Ru2O3–Fe3O4 (1.3) 0
8 Rh2O3–Fe3O4 (0.4) 0
9 PdO–Fe3O4 (1.2) 0
10 AgO2–Fe3O4 (1.3) 0
11 OsO2–Fe3O4 (0.5) 0
12 IrO2–Fe3O4 (0.1) 0
13 PtO–Fe3O4 (0.5) 0
14 Au2O3–Fe3O4 (0.1) 0
15 PdO/Cu–Fe3O4 (1.5/0.9) 42
16 NiO/Cu–Fe3O4 (0.9/0.9) 98
17 NiO/Cu–Fe3O4 (0.2/0.2) 15
18 NiO/Cu–Fe3O4 (1.8/1.8) >99d
19 NiO–Fe3O4 (1.0) + CuO–Fe3O4 (0.9) 87
20 CuO (0.9) 78
21 NiO (0.9) 12
22 Cu(OH)2 (0.9) 58
23 Ni(OH)2 (0.9) 11
24 NiO (0.9) + CuO (0.9) 76
25 Ni(OH)2 (0.9) + Cu(OH)2 (0.9) 62


Then, a series of bimetallic derivatives were studied, finding that Pd/Cu system19c could render the expected product 3a (entry 15). Very recently, different bimetallic Ni–Cu/C composite catalysts20 have been tested in the simple cycloaddition of azides and terminal alkynes and these results prompted us to prepare the corresponding bimetallic one impregnated on magnetite. Its reaction gave the expected product with an excellent result (entry 16). The decrease of the amount of Ni–Cu catalyst had an important detrimental effect, meanwhile its increase had a marginal benefit (compare entries 16–18).

Faced with the excellent result obtained with the bimetallic nickel–copper catalyst we wondered if the yield was a result of a simple addition of two independent catalytic sites or was it the result of some type of synergic effect. To answer that question, the reaction was repeated using both catalysts (the copper and the nickel one) with almost the same loading and the result seemed to be the addition of the activity of both catalysts (compare entries 5 and 6 with entry 19). Therefore, we believe that the bimetallic catalyst develops a synergetic effect that makes it superior to the addition of both parts, although the nature of this positive interaction is unknown.

Finally, the unsupported metal catalysts were tested. Thus, the reaction using CuO alone gave the expected product 3a with a good result (Table 3, entry 20), meanwhile the related nickel oxide gave a worse result (entry 21). When the reaction was repeated with the corresponding metal hydroxide derivatives the yields were slightly lower (entries 22 and 23). The equimolecular mixture of both metallic catalysts did not show any improvement of the result obtained by the copper derivative (compare entries 20, 22 and 24, 25, respectively).

The bimetallic Ni–Cu catalyst could be recycled and reused tenfold, just by collection of the catalyst with a magnet, washing with toluene and ethanol, and drying, without any depreciation in its activity (Fig. 2).


image file: c4ra03149k-f2.tif
Fig. 2 Recycling of NiO/Cu–Fe3O4 catalyst for the multicomponent reaction.

The phenomenon of leaching was studied by ICP-MS analysis of the resulting reaction solution mixture, and 1.1, and 0.2% of the initial amount of copper, and nickel, respectively, was detected (0.006% of iron). The TEM images of the recycled catalyst showed a small change in the particle size from 3.1 ± 1.7 nm of the freshly prepared catalyst to 4.7 ± 2.4 nm for the recycled one. Moreover, XPS data analysis of bimetallic catalyst showed only NiO, CuO and Cu2O species (Fig. 3), which was confirmed by Auger spectroscopy (see ESI). However, the recycled one showed the presence of Ni(OH)2 as well as Cu(OH)2. These small changes, in particle size and the nickel species seemed not to affect the activity of the bimetallic catalyst, since it could be reused several times with similar activity.


image file: c4ra03149k-f3.tif
Fig. 3 X-Ray photoelectron spectroscopy of the fresh NiO/Cu–Fe3O4 catalyst.

To know if the reaction took place by the leached copper or nickel species to the organic medium, we performed the standard multicomponent reaction (Table 3, entry 16). After that, the catalyst was removed carefully by a magnet at high temperature, and washed with toluene. The solvents of the above solution, without catalyst, were removed under low pressure and alkyne 1a, sodium azide (6) and 4-bromobenzyl alcohol were added to the above residue. The resulting mixture was heated again at 50 °C for 24 h. The analysis of crude mixture, after hydrolysis, revealed the formation of compound 3a in 95% (catalyzed process) and product 3b in less than 1% yield by GC-analysis (compare with entry 2 in Table 4). Therefore, we could exclude that the final leached copper–nickel species were responsible for the reaction results under the standard conditions.

Table 4 Multicomponent cycloaddition

image file: c4ra03149k-u4.tif

Entry R1 R2 No Yielda (%)
a Isolated yield after column chromatography. b Reaction performed during 4 days.
1 Ph Ph 3a 98
2 Ph 4-BrC6H4 3b >99
3 Ph 3-BrC6H4 3c >99
4 Ph 2-BrC6H4 3d >99b
5 Ph 2-MeC6H4 3e 59b
6 Ph 3-MeC6H4 3f 50
7 Ph 3,5-(MeO)2C6H3 3g 89
8 4-ClC6H4 Ph 3h 80b
9 4-ClC6H4 4-BrC6H4 3i >99
10 2-ClC6H4 Ph 3j 45b
11 4-BrC6H4 Ph 3k 42b
12 4-BrC6H4 3-MeC6H4 3l 90
13 4-MeOC6H4 Ph 3m 42b
14 3-MeC6H4 Ph 3n 55b
15 3-MeC6H4 3-BrC6H4 3o 86
16 3-MeC6H4 3-MeC6H4 3p 49
17 C6H4(CO)2N Ph 3q 37b


Once the catalytic activity and the recyclability of bimetallic catalyst were proved, the scope of the reaction was tested (Table 4). The reaction gave excellent results independently of substituent position on the aromatic ring of the bromide 5 (entries 2–4). The electronic nature of substituent on the aromatic ring of the bromide 5 seemed not to have influenced on the results (compare entries 1–7), since the results disagrees with the Hammett constants. Also, the reaction was accomplished with akynes 1 with different groups in the aromatic ring, with no clear correlation of the reached yields with the electronic nature of substituents (entries 8–16). The reaction with 2-(bromomethyl)isoindoline-1,3-dione gave the expected compound 3q in a modest yield (entry 17). However, it should be pointed out that the reactions using less electrophilic reagents such as aliphatic bromide (1-bromododecane) or benzyl chloride, failed after seven days under standard conditions, recovering unchanged the starting alkyne, as well as in the case of using either an aliphatic substituted alkyne (oct-1-yne).

Then, the initial source of benzyl azide was tested (Scheme 1). The reaction with benzylic alcohols failed after six days, recovering unchanged the initial alkyne. The reaction also failed using the silyl ether 7b. However, the reaction using benzyl mesylate gave a modest yield (35%) after 2 days reaction time. When the reaction time was increased up to 6 days a reasonable yield was isolated (75%). When the reaction was performed with benzyl tosylate (7d) the result was very modest.


image file: c4ra03149k-s1.tif
Scheme 1 Multicomponent cycloaddition with benzyl derivatives.

The multicomponent reaction with symmetrical internal alkynes 8 gave the expected compound 9 with very modest yield (Scheme 2). This result highlighted the possible selectivity of catalyst, and in order to confirm this, the reaction of benzyl bromide (5a, 2 equiv.), sodium azide (6, 2 equiv.), ethynylbenzene (1a, 1 equiv.) and 1,2-diphenylethyne (8a, 1 equiv.) was performed under standard conditions, finding exclusively the compound 3a (94%) from the analysis of crude mixture.


image file: c4ra03149k-s2.tif
Scheme 2 Multicomponent cycloaddition with internal alkynes.

Once the scope of the reaction was studied, we faced the problem of reaction sequentiality. For this proposal, we carried the reaction with the dibromide derivative 10, and a double amount of sodium azide (6), obtaining after six days the azide 11 with a moderate yield (Scheme 3).


image file: c4ra03149k-s3.tif
Scheme 3 Sequential multicycloaddition process.

The GC-MS analysis of crude mixture did not show the presence of corresponding bis-triazole, with the relate bis-azide derivative being the main by-product. The isolated azide 11 was submitted to another cycloaddition process, yielding the unsymmetrical bis-triazole derivative 12 with good yield. This approach highlights the possibilities of the catalyst in the synthesis of different substituted triazoles.

Conclusions

We have demonstrated that the new bimetallic catalyst derived from nickel and copper supported on magnetite was a good catalyst for the multicomponent reaction of terminal alkynes, sodium azide, and benzyl bromide derivatives. The presence of both metallic species on the surface of magnetite seemed to have a positive and synergetic effect. The catalyst loading was the lowest ever published for a catalyst of copper anchored on any type of iron support, and being in the lowest level for any type of the heterogeneous ones. The catalyst could be easily removed from the reaction media just by magnetic decantation, and it could be reused up to ten times without any negative effect on the initial results.

Experimental

General

XPS analyses were carried out on a VG-Microtech Mutilab. XRD analyses were obtained on a BRUKER D-8 ADVANCE diffractometer with Göebel mirror, with a high temperature chamber (up to 900 °C), with a X-ray generator KRISTALLOFLEX K 760-80F (3 kW, 20–60 kV and 5–80 mA). TEM images were obtained on a JEOL, model JEM-2010 equipped with an X-ray detector OXFORD INCA Energy TEM 100 for microanalysis (EDS). XRF analyses were obtained on a PHILIPS MAGIX PRO (PW2400) X-ray spectrometer equipped with a rhodium X-ray tube and a beryllium window. BET isotherms were carried out on a AUTOSORB-6 (Quantachrome), using N2. Melting points were obtained with a Reichert Thermovar apparatus. NMR spectra were recorded on a Bruker AC-300 (300 MHz for 1H and 75 MHz for 13C) using CDCl3 as a solvent and TMS as internal standard for 1H and 13C; chemical shifts are given in δ (parts per million) and coupling constants (J) in Hertz. FT-IR spectra were obtained on a JASCO 4100LE (Pike Miracle ATR) spectrophotometer. Mass spectra (EI) were obtained at 70 eV on a Himazdu QP-5000 spectrometer, giving fragment ions in m/z with relative intensities (%) in parentheses. The chromatographic analyses (GLC) were determined with a Hewlett Packard HP-5890 instrument equipped with a flame ionization detector and 12 m HP-1 capillary column (0.2 mm diam., 0.33 mm film thickness, OV-1 stationary phase), using nitrogen (2 mL min−1) as a carrier gas, Tinjector = 275 °C, Tdetector = 300 °C, Tcolumn = 60 °C (3 min) and 60–270 °C (15 °C min−1), P = 40 kPa. Thin layer chromatography (TLC) was carried out on Schleicher & Schuell F1400/LS 254 plates coated with a 0.2 mm layer of silica gel; detection by UV254 light, staining with phosphomolybdic acid [25 g phosphomolybdic acid, 10 g Ce(SO4)2·4H2O, 60 mL of concentrated H2SO4 and 940 mL H2O]. Column chromatography was performed using silica gel 60 of 40–63 mesh. All reagents were commercially available (Acros, Aldrich, Fluorochem) and were used as received. The ICP-MS analyses were carried out on a Thermo Elemental VGPQ-ExCell spectrometer. The Elemental Analysis was performed on a Elemental Microanalyzer Thermo Finningan Flash 1112 Series.

General procedure for the preparation of NiO/Cu–Fe3O4 catalyst

To a stirred solution of CuCl2 (1 mmol, 130 mg) and NiCl2·H2O (1 mmol, 130 mg) in deionized water (120 mL) was added commercially available Fe3O4 (4 g, 17 mmol, powder < 5 μm, BET area: 9.86 m2 g−1). After 10 minutes at room temperature, the mixture was slowly basified with NaOH (1 M) until pH around 13. The mixture was stirred during one day at room temperature in air. After that, the catalyst was filtered and washed several times with deionized water (3 × 10 mL). The solid was dried at 100 °C during 24 h in a standard glassware oven, obtaining thereafter the expected catalyst.

General procedures for the preparation of the products

To a stirred solution of sodium azide (6, 2 mmol) and benzyl halide (5, 2 mmol) were added NiO/Cu–Fe3O4 (50 mg, 0.9 mol% of Ni and 0.9 mol% of Cu) and the corresponding alkyne (1 or 8, 1 mmol). The resulting mixture was stirred at 50 °C until the end of the reaction. The catalyst was removed by a magnet and the resulting mixture was quenched with deionized water and extracted with AcOEt (3 × 5 mL). The organic phases were dried over MgSO4, followed by evaporation under reduced pressure to remove the solvent. The product was usually purified by chromatography on silica gel (hexane–ethyl acetate) to give the corresponding products 3 or 9 (see ESI). The chromatographic analyses were determined with a flame ionization detector and a 30 m capillary column (0.32 mm diam. 0.25 μm film thickness, HP-5 stationary phase), using nitrogen (2 mL min−1) as carrier gas, P = 10 psi, T(injector) = 270 °C and T(detector) = 300 °C; tR values are given under these conditions. Physical and spectroscopic data, only for new compounds, follow:
1-Benzyl-4-phenyl-1H-1,2,3-triazole (3a)10e. White solid; m.p. 104–108 °C (hexane–AcOEt); IR (cm−1): 3021, 2920, 1450, 1223; 1H NMR (300 MHz, CDCl3): δ 5.57 (s, 2H), 7.3–7.45 (m, 8H), 7.66 (s, 1H), 7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 54.2, 119.4, 125.7 (2C), 128.0 (2C), 128.1, 128.8 (3C), 129.1 (2C), 130.5, 134.7, 148.2; EI-MS m/z: 235 (M+, 22%), 207 (14), 206 (71), 180 (13), 179 (11), 116 (100), 104 (21), 91 (84), 89 (29), 65 (20), 63 (11).
1-(4-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (3b)21. White solid; m.p. 150–152 °C (hexane–AcOEt); IR (cm−1): 3082, 1489, 1221, 1073; 1H NMR (300 MHz, CDCl3): δ 5.5 (s, 2H), 7.17 (d, 3J(H,H) = 8.4 Hz, 2H), 7.3–7.35 (m, 1H), 7.4–7.45 (m, 2H), 7.52 (d, 3J(H,H) = 8.4 Hz, 2H), 7.7 (s, 1H), 7.8–7.85 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 53.5, 119.4, 122.9, 125.7 (2C), 128.3, 128.8 (2C), 129.6 (2C), 130.3, 132.3 (2C), 133.6, 148.4; EI-MS m/z: 315 (M+ + 2, 9%), 313 (M+, 10%), 286 (16), 284 (17), 206 (20), 171 (24), 169 (25), 116 (100), 90 (19), 89 (28).
1-(3-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (3c)14. White solid; m.p. 85–87 °C (hexane–AcOEt); IR (cm−1): 3084, 1460, 1432, 1222, 1046; 1H NMR (300 MHz, CDCl3): δ 5.54 (s, 2H), 7.2–7.25 (m, 2H), 7.3–7.35 (m, 1H), 7.4–7.45 (m, 2H), 7.45–7.5 (m, 2H), 7.71 (s, 1H), 7.8–7.85 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 53.4, 119.5, 123.1, 125.7 (2C), 126.5, 128.3, 128.8 (2C), 130.2, 130.7, 130.9, 131.9, 136.8, 148.3; EI-MS m/z: 315 (M+ + 2, 8%), 313 (M+, 8%), 286 (14), 284 (14), 206 (21), 171 (22), 169 (23), 116 (100), 90 (20), 89 (29).
1-(2-Bromobenzyl)-4-phenyl-1H-1,2,3-triazole (3d)14. White solid; m.p. 101–103 °C (hexane–AcOEt); IR (cm−1): 3051, 1459, 1430, 1220, 1043; 1H NMR (300 MHz, CDCl3): δ 5.7 (s, 2H), 7.15–7.25 (m, 2H), 7.3–7.35 (m, 2H), 7.4–7.45 (m, 2H), 7.62 (dd, 3J(H,H) = 7.9 Hz, 4J(H,H) = 1.0 Hz, 1H), 7.78 (s, 1H), 7.82 (d, 3J(H,H) = 7.3 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 53.8, 119.8, 123.4, 125.7 (2C), 128.2 (2C), 128.8 (2C), 130.1, 130.2, 130.4, 133.2, 134.2, 148.1; EI-MS m/z: 315 (M+ + 2, 12%), 313 (M+, 11%), 208 (12), 207 (59), 206 (93), 184 (11), 171 (31), 169 (32), 117 (11), 116 (100), 103 (13), 91 (21), 90 (24), 89 (34), 63 (10).
1-(2-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole (3e)12h. White solid; m.p. 98–99 °C (hexane–AcOEt); IR (cm−1): 3096, 1462, 1216; 1H NMR (300 MHz, CDCl3): δ 2.31 (s, 3H), 5.6 (s, 2H), 7.2–7.25 (m, 3H), 7.3–7.35 (m, 2H), 7.35–7.45 (m, 2H), 7.54 (s, 1H), 7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 19.0, 52.5, 119.2, 125.6 (2C), 126.7, 128.1, 128.8 (2C), 129.2, 129.4, 130.5, 131.1, 132.5, 137.0, 148.0; EI-MS m/z: 249 (M+, 22%), 220 (35), 207 (17), 206 (11), 118 (31), 117 (39), 116 (100), 105 (63), 104 (10), 103 (15), 89 (23), 79 (14), 77 (21).
1-(3-Methylbenzyl)-4-phenyl-1H-1,2,3-triazole (3f)21. White solid; m.p. 95–96 °C (hexane–AcOEt); IR (cm−1): 3089, 1464, 1222; 1H NMR (300 MHz, CDCl3): δ 2.34 (s, 3H), 5.52 (s, 2H), 7.1–7.2 (m, 3H), 7.25–7.45 (m, 4H), 7.66 (s, 1H), 7.8–7.85 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 21.3, 54.2, 119.5, 125.1, 125.6 (2C), 128.1, 128.7, 128.8 (2C), 129.0, 129.5, 130.5, 134.5, 139.0, 148.1; EI-MS m/z: 249 (M+, 29%), 221 (13), 220 (61), 206 (36), 179 (20), 118 (14), 117 (17), 116 (100), 105 (66), 103 (14), 89 (24), 79 (13), 77 (20).
1-(3,5-Dimethoxybenzyl)-4-phenyl-1H-1,2,3-triazole (3g)12h. White solid; m.p. 90–92 °C (hexane–AcOEt); IR (cm−1): 3086, 1610, 1197; 1H NMR (300 MHz, CDCl3): δ 3.76 (s, 6H), 5.49 (s, 2H), 6.44 (s, 3H), 7.3–7.35 (m, 1H), 7.35–7.4 (m, 2H), 7.68 (s, 1H), 7.75–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 54.2, 55.4 (2C), 100.4, 106.0 (2C), 119.5, 125.6 (2C), 128.1, 128.8 (2C), 130.5, 136.7, 148.2, 161.2 (2C); EI-MS m/z: 296 (M+ + 1, 13%), 295 (M+, 74%), 281 (14), 266 (41), 252 (10), 239 (32), 236 (19), 209 (21), 208 (15), 207 (61), 164 (36), 152 (13), 151 (100), 117 (12), 116 (100), 91 (19), 89 (21), 78 (11), 77 (18), 65 (11).
1-Benzyl-4-(4-chlorophenyl)-1H-1,2,3-triazole (3h)15b. White solid; m.p. 125–127 °C (hexane–AcOEt); IR (cm−1): 3060, 1481, 1222, 1069; 1H NMR (300 MHz, CDCl3): δ 5.57 (s, 2H), 7.3–7.4 (m, 7H), 7.65 (s, 1H), 7.72 (d, 3J(H,H) = 8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 54.3, 60.4, 119.5, 126.9 (2C), 128.1 (2C), 128.8, 129.0 (2C), 129.2 (2C), 133.9, 134.5, 147.1; EI-MS m/z: 271 (M+ + 2, 9%), 269 (M+, 26%), 242 (23), 241 (15), 240 (70), 207 (14), 206 (27), 179 (29), 152 (36), 151 (10), 150 (100), 125 (10), 123 (25), 104 (20), 102 (11), 91 (93), 65 (22).
1-(4-Bromobenzyl)-4-(4-chlorophenyl)-1H-1,2,3-triazole (3i). White solid; m.p. 146–150 °C (hexane–AcOEt); IR (cm−1): 1487, 1456, 1227, 1092, 1072; 1H NMR (300 MHz, CDCl3): δ 5.53 (s, 2H), 7.18 (d, 3J(H,H) = 8.4 Hz, 2H), 7.36 (d, 3J(H,H) = 8.5 Hz, 2H), 7.51 (d, 3J(H,H) = 8.4 Hz, 2H), 7.66 (s, 1H), 7.72 (d, 3J(H,H) = 8.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 53.5, 119.5, 123.0, 126.9 (2C), 128.8, 129.0 (2C), 129.6 (2C), 132.3 (2C), 133.5, 133.9, 147.3; EI-MS m/z: 349 (M+ + 2, 17%), 347 (M+, 13%), 320 (19), 318 (14), 240 (26), 207 (10), 171 (27), 169 (29), 152 (33), 151 (10), 150 (100), 123 (16), 90 (19), 89 (16); HRMS (ESI): m/z calcd for C15H11BrClN3: 346.9825; found: 346.9828.
1-Benzyl-4-(2-chloropehnyl)-1H-1,2,3-triazole (3j)22. White solid; m.p. 77–78 °C (hexane–AcOEt); IR (cm−1): 3083, 1461, 1227, 1056; 1H NMR (300 MHz, CDCl3): δ 5.61 (s, 2H), 7.2–7.45 (m, 8H), 8.12 (s, 1H), 8.22 (dd, 3J(H,H) = 7.8 Hz, 4J(H,H) = 1.8 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 54.2, 123.1, 127.1, 127.9 (2C), 128.7, 129.0, 129.1 (2C), 129.2, 129.8, 130.1, 131.1, 134.6, 144.4; EI-MS m/z: 271 (M+ + 2, 6%), 269 (M+, 17%), 242 (12), 240 (36), 206 (40), 179 (30), 152 (28), 150 (87), 123 (14), 104 (26), 102 (10), 91 (100), 65 (19).
1-Benzyl-4-(4-bromophenyl)-1H-1,2,3-triazole (3k)6b. White solid; m.p. 143–145 °C (hexane–AcOEt); IR (cm−1): 3070, 1477, 1449, 1222, 1050; 1H NMR (300 MHz, CDCl3): δ 5.56 (s, 2H), 7.3–7.4 (m, 5H), 7.5–7.55 (m, 2H), 7.65–7.7 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 54.3, 119.5, 122.0, 127.2 (2C), 128.1 (2C), 128.8, 129.1 (2C), 129.4, 131.9 (2C), 134.4, 147.1; EI-MS m/z: 315 (M+ + 2, 23%), 313 (M+, 24%), 287 (10), 286 (54), 285 (11), 284 (53), 207 (12), 206 (40), 204 (11), 196 (73), 194 (75), 179 (32), 178 (12), 169 (13), 167 (13), 115 (11), 104 (18), 102 (12), 91 (100), 88 (14), 65 (19).
4-(4-Bromophenyl)-1-(3-methylbenzyl)-1H-1,2,3-triazole (3l). White solid; m.p. 127–128 °C (hexane–AcOEt); IR (cm−1): 3016, 1450, 1225, 1069; 1H NMR (300 MHz, CDCl3): δ 2.35 (s, 3H), 5.53 (s, 2H), 7.11 (d, 3J(H,H) = 7.3 Hz, 2H), 7.18 (d, 3J(H,H) = 7.3 Hz, 1H), 7.28 (d, 3J(H,H) = 7.3 Hz, 1H), 7.52 (d, 3J(H,H) = 8.6 Hz, 2H), 7.65 (s, 1H), 7.67 (d, 3J(H,H) = 8.6 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 21.3, 54.3, 119.5, 122.0, 125.2, 127.2 (2C), 128.8, 129.0, 129.5, 129.6, 131.9 (2C), 134.3, 139.1, 147.1; EI-MS m/z: 329 (M+ + 2, 24%), 327 (M+, 22%), 300 (34), 298 (36), 286 (27), 284 (26), 220 (21), 207 (22), 196 (70), 194 (76), 193 (27), 178 (12), 169 (12), 167 (12), 118 (18), 117 (11), 115 (15), 105 (100), 103 (20), 102 (14), 88 (15), 79; elemental analysis calcd for C16H14BrN3: C = 58.55; H = 4.30; N = 12.80; found: C = 58.50; H = 4.29; N = 12.69.
1-Benzyl-4-(4-methoxyphenyl)-1H-1,2,3-triazole (3m)15b. White solid; m.p. 135–136 °C (hexane–AcOEt); IR (cm−1): 1455, 1250; 1H NMR (300 MHz, CDCl3): δ 3.82 (s, 3H), 5.55 (s, 2H), 6.93 (d, 3J(H,H) = 8.9 Hz, 2H), 7.25–7.4 (m, 5H), 7.58 (s, 1H), 7.72 (d, 3J(H,H) = 8.9 Hz, 2H); 13C NMR (75 MHz, CDCl3): δ 54.1, 55.3, 114.2 (2C), 118.6, 123.2, 127.0 (2C), 128.0 (2C), 128.7, 129.1 (2C), 134.7, 148.0, 159.5; EI-MS m/z: 266 (M+ + 1, 6%), 265 (M+, 35%), 237 (21), 236 (100), 222 (17), 210 (10), 209 (20), 206 (19), 194 (10), 193 (10), 179 (16), 160 (11), 146 (82), 119 (29), 91 (63), 89 (15), 76 (13), 65 (24).
1-Benzyl-4-(m-tolyl)-1H-1,2,3-triazole (3n)22. White solid; m.p. 145–146 °C (hexane–AcOEt); IR (cm−1): 3031, 1454, 1220; 1H NMR (300 MHz, CDCl3): δ 2.38 (s, 3H), 5.58 (s, 2H), 7.12 (d, 3J(H,H) = 7.6 Hz, 1H), 7.25–7.45 (m, 6H), 7.58 (d, 3J(H,H) = 7.6 Hz, 1H), 7.65–7.7 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 21.4, 54.2, 119.4, 122.8, 126.3, 128.0 (2C), 128.7, 128.8, 128.9, 129.1 (2C), 130.3, 134.7, 138.5, 148.3; EI-MS m/z: 249 (M+, 25%), 221 (13), 220 (58), 206 (10), 179 (12), 131 (11), 130 (100), 104 (13), 103 (14), 91 (70), 77 (14), 65 (14).
1-(3-Bromobenzyl)-4-(m-tolyl)-1H-1,2,3-triazole (3o)6b. White solid; m.p. 90–93 °C (hexane–AcOEt); IR (cm−1): 3036, 1429, 1223, 1084; 1H NMR (300 MHz, CDCl3): δ 2.35 (s, 3H), 5.48 (s, 2H), 7.1–7.3 (m, 4H), 7.4–7.45 (m, 2H), 7.57 (d, 3J(H,H) = 7.8 Hz, 1H), 7.65 (s, 1H), 7.7 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 21.3, 53.2, 119.5, 122.6, 122.9, 126.2, 126.4, 128.6, 128.9, 130.1, 130.5, 130.7, 131.7, 136.8, 138.4, 148.3; EI-MS m/z: 329 (M+ + 2, 11%), 327 (M+, 12%), 300 (18), 298 (17), 220 (18), 207 (39), 171 (24), 169 (22), 131 (11), 130 (100), 103 (814), 90 (14), 89 (13).
1-(3-Methylbenzyl)-4-(m-tolyl)-1H-1,2,3-triazole (3p). White solid; m.p. 127–128 °C (hexane–AcOEt); IR (cm−1): 3017, 1446, 1220; 1H NMR (300 MHz, CDCl3): δ 2.34 (s, 3H), 2.37 (s, 3H), 5.52 (s, 2H), 7.1–7.2 (m, 4H), 7.25–7.3 (m, 2H), 7.57 (d, 3J(H,H) = 7.8 Hz, 1H), 7.64 (s, 1H), 7.66 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 21.3, 21.4, 54.2, 119.4, 122.7, 125.1, 126.3, 128.6, 128.7, 128.8, 129.0, 129.5, 130.4, 134.6, 138.4, 139.0, 148.2; EI-MS m/z: 264 (M+ + 1, 7%), 263 (M+, 35%), 235 (14), 234 (62), 220 (41), 207 (18), 193 (18), 131 (10), 130 (100), 118 (15), 105 (62), 103 (22), 79 (10), 77 (25); HRMS (ESI): mz calcd for C17H17N3 263.1422; found: 263.1414.
2-((4-Phenyl-1H-1,2,3-triazol-1-yl)methyl)isoindoline-1,3-dione (3q). White solid; m.p. 186–188 °C (hexane–AcOEt); IR (cm−1): 1715; 1H NMR (300 MHz, CDCl3): δ 6.26 (s, 2H), 7.25–7.4 (m, 3H), 7.75–7.85 (m, 4H), 7.9–7.95 (m, 2H), 8.11 (s, 1H); 13C NMR (75 MHz, CDCl3): δ 49.7, 120.5, 124.1 (2C), 125.8 (2C), 128.3, 128.8 (2C), 130.1, 131.4 (2C), 134.9 (2C), 148.4, 166.5 (2C); EI-MS m/z: 304 (M+, 31%), 281 (11), 248 (10), 208 (10), 207 (40), 161 (11), 160 (100), 133 (15), 116 (31), 104 (16), 77 (15), 76 (14); elemental analysis calcd for C17H12N4O2: C = 67.10; H = 3.97; N = 18.41; found: C = 67.11; H = 3.96; N = 18.42.
1-Benzyl-4,5-diphenyl-1H-1,2,3-triazole (9a)23. White solid; m.p. 109–110 °C (hexane–AcOEt); IR (cm−1): 3058, 1449, 1246; 1H NMR (300 MHz, CDCl3): δ 5.41 (s, 2H), 7.0–7.05 (m, 2H), 7.1–7.15 (m, 2H), 7.2–7.3 (m, 6H), 7.4–7.5 (m, 3H), 7.55–7.6 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 52.0, 126.7 (2C), 127.5 (2C), 127.7, 127.8, 128.1, 128.4 (2C), 128.7 (2C), 129.1 (2C), 129.6, 130.1 (2C), 130.9, 133.9, 135.3, 144.5; EI-MS m/z: 311 (M+, 17%), 193 (16), 192 (100), 165 (23), 91 (75), 89 (16).
1-Benzyl-4,5-bis(4-butylphenyl)-1H-1,2,3-triazole (9b). Pale yellow oil; IR (cm−1): 3030, 1455, 1245; 1H NMR (300 MHz, CDCl3): δ 0.89 (t, 3J(H,H) = 7.3 Hz, 3H), 0.97 (t, 3J(H,H) = 7.3 Hz, 3H), 1.25–1.45 (m, 4H), 1.50–1.7 (m, 4H), 2.55 (t, 3J(H,H) = 7.6 Hz, 2H), 2.67 (t, 3J(H,H) = 7.6 Hz, 2H), 5.39 (s, 2H), 7.0–7.1 (m, 6H), 7.2–7.25 (m, 5H), 7.45–7.5 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 13.9, 14.0, 22.3 (2C), 33.3, 35.3, 35.5, 51.9, 125.1, 126.5 (2C), 127.0, 127.5 (2C), 128.0, 128.4 (2C), 128.6 (2C), 129.1 (2C), 129.9 (2C), 133.6, 135.5, 142.4, 144.4, 144.5; EI-MS m/z: 423 (M+, 0%), 361 (16), 360 (69), 359 (24), 328 (13), 283 (18), 282 (20), 281 (72), 209 (13), 208 (18), 207 (100); elemental analysis calcd for C29H33N3: C = 82.23; H = 7.85; N = 9.92; found: C = 82.26; H = 7.75; N = 9.89.
1-(3-Bromobenzyl)-4,5-diphenyl-1H-1,2,3-triazole (9c). White solid; m.p. 70–73 °C (hexane–AcOEt); IR (cm−1): 3054, 1572, 1241; 1H NMR (300 MHz, CDCl3): δ 5.37 (s, 2H), 6.97 (d, 3J(H,H) = 7.7 Hz, 1H), 7.1–7.15 (m, 4H), 7.2–7.3 (m, 3H), 7.35–7.6 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 51.4, 122.7, 126.2, 126.6 (2C), 127.6 (2C), 127.8, 128.4 (2C), 129.3 (2C), 129.9, 130.0 (2C), 130.3, 130.7, 131.4, 133.8, 137.3, 144.6; EI-MS m/z: 391 (M+ + 2, 6%), 389 (M+, 6%), 193 (15), 192 (100), 165 (28), 89 (15); elemental analysis calcd for C21H16BrN3: C = 64.63; H = 4.13; N = 10.77; found: C = 64.65; H = 4.17; N = 10.69.
1-(2′-(Azidomethyl)-[1,1′-biphenyl]-2-yl)-4-phenyl-1H-1,2,3-triazole (11). Colorless oil; IR (cm−1): 2092, 1242; 1H NMR (300 MHz, CDCl3): δ 3.95–4.05 (m, 2H), 5.25–5.35 (m, 2H), 7.15–7.2 (m, 1H), 7.2–7.3 (m, 3H), 7.35–7.5 (m, 8H), 7.7–7.8 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 51.7, 52.3, 119.7, 125.5 (2C), 128.0, 128.4 (2C), 128.5, 128.6, 128.7 (2C), 128.9, 129.6, 129.9, 130.1, 132.9, 133.5, 139.1 (2C), 147.5; EI-MS m/z: 194 (M+ − 172, 16%), 193 (100), 192 (28), 166 (14), 165 (56), 164 (10), 163 (10); elemental analysis calcd for C22H18N6: C = 72.11; H = 4.95; N = 22.94; found: C = 72.12; H = 4.98; N = 22.98.
4-(4-Methoxyphenyl)-1-((2′-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)-[1,1′-biphenyl]-2-yl)methyl)-1H-1,2,3-triazole (12). Pale yellow oil; IR (cm−1): 1245; 1H NMR (300 MHz, CDCl3): δ 3.83 (s, 3H), 5.1–5.25 (m, 2H), 5.3–5.35 (m, 2H), 6.9–6.95 (m, 2H), 7.25–7.3 (m, 3H), 7.3–7.45 (m, 9H), 7.47 (s, 1H), 7.6–7.65 (m, 2H), 7.7–7.75 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 51.8, 55.3, 60.3, 114.2 (2C), 114.5, 119.5, 120.4, 123.0, 125.6 (2C), 126.9 (2C), 128.1, 128.6 (2C), 128.7 (2C), 128.8, 129.1, 129.9, 130.0, 130.1, 130.3, 133.3 (2C), 138.6 (2C), 147.4 (2C), 159.6; EI-MS m/z: 499 (M+ + 1, 5%), 498 (M+, 14%), 339 (11), 325 (15), 324 (13), 309 (11), 295 (16), 294 (15), 292 (10), 283 (14), 282 (62), 180 (27), 179 (100), 178 (61), 166 (10), 165 (36), 146 (16), 133 (12), 132 (11), 116 (19), 89 (10); elemental analysis calcd for C31H26N6O: C = 74.68; H = 5.26; N = 16.86; found: C = 74.69; H = 5.28; N = 16.87.

Acknowledgements

This work was supported by the current Spanish Ministerio de Economía y Competitividad (CTQ2011-24151) and University of Alicante. J.M.P. thanks to M.E.C. for a fellowship through the FPI program. We gratefully acknowledge the polishing of our English by Mrs Oriana C. Townley.

Notes and references

  1. A. Michael, J. Prakt. Chem., 1893, 48, 94–95 CrossRef.
  2. C. W. Tornøe, C. Christensen and M. Medal, J. Org. Chem., 2002, 67, 3057–3064 CrossRef PubMed.
  3. V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596–2599 CrossRef CAS.
  4. (a) V. D. Bock, H. Hiemstra and J. H. van Maarseveen, Eur. J. Org. Chem., 2006, 51–68 CrossRef CAS; (b) M. Medal and C. W. Tornøe, Chem. Rev., 2008, 108, 2952–3015 CrossRef PubMed; (c) F. Amblard, J. H. Cho and R. F. Schinazi, Chem. Rev., 2009, 109, 4207–4220 CrossRef CAS PubMed; (d) J. E. Hein and V. V. Fokin, Chem. Soc. Rev., 2010, 39, 1302–1315 RSC; (e) L. Liang and D. Astruc, Coord. Chem. Rev., 2011, 255, 2933–2945 CrossRef CAS PubMed; (f) S. Díez-González, Catal. Sci. Technol., 2011, 1, 166–178 RSC; (g) T. Jin, M. Yan and Y. Yamamoto, ChemCatChem, 2012, 4, 1217–1229 CrossRef CAS.
  5. C. Schilling, N. Jung and S. Bräse, in Organic Azides: Syntheses and Applications, ed. S. Bräse and K. Banert, Wiley-VCH, Weinheim, 2010, pp. 269–284 Search PubMed.
  6. (a) J. McNulty, K. Keskar and R. Vemula, Chem.–Eur. J., 2011, 17, 14727–14730 CrossRef CAS PubMed; (b) J. McNulty and K. Keskar, Eur. J. Org. Chem., 2012, 5462–5470 CrossRef CAS.
  7. (a) P. Paul and K. Nag, Inorg. Chem., 1987, 26, 2969–2974 CrossRef CAS; (b) R. Nasani, M. Saha, S. M. Mobin and S. Mukhopadhyay, Polyhedron, 2013, 55, 24–36 CrossRef CAS PubMed.
  8. (a) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, Tetrahedron Lett., 2009, 50, 2358–2362 CrossRef CAS PubMed; (b) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, Eur. J. Org. Chem., 2010, 1875–1884 CrossRef CAS; (c) T. Jin, M. Yan, Menggernbateer, T. Minato, M. Bao and Y. Yamamoto, Adv. Synth. Catal., 2011, 353, 3095–3100 CrossRef CAS; (d) T. L. Cook, J. A. Walker and J. Mack, Green Chem., 2013, 15, 617–619 RSC.
  9. (a) J. Y. Kim, J. C. Park, H. Kang, H. Song and K. H. Park, Chem. Commun., 2010, 46, 439–441 RSC; (b) C. Shao, R. Zhu, S. Luo, Q. Zhang, X. Wang and Y. Hu, Tetrahedron Lett., 2011, 52, 3782–3785 CrossRef CAS PubMed; (c) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, Synlett, 2012, 23, 2179–2182 CrossRef CAS PubMed; (d) H. Woo, H. Kang, A. Kim, S. Jang, J. C. Park, S. Park, B.-S. Kim, H. Song and K. H. Park, Molecules, 2012, 17, 13235–13252 CrossRef CAS PubMed.
  10. (a) B. H. Lipshutz and B. R. Taft, Angew. Chem., Int. Ed., 2006, 45, 8235–8238 CrossRef CAS PubMed; (b) C.-T. Lee, S. Huang and B. H. Lipshutz, Adv. Synth. Catal., 2009, 351, 3139–3142 CrossRef CAS; (c) M. Fuchs, W. Goessler, C. Pilger and C. O. Kappe, Adv. Synth. Catal., 2010, 352, 323–328 CrossRef CAS; (d) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, Adv. Synth. Catal., 2010, 352, 3208–3214 CrossRef CAS; (e) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, Org. Biomol. Chem., 2011, 9, 6385–6395 RSC; (f) F. Alonso, Y. Moglie, G. Radivoy and M. Yus, J. Org. Chem., 2011, 76, 8394–8405 CrossRef CAS PubMed.
  11. (a) U. Sirion, Y. J. Bae, B. S. Lee and D. Y. Chi, Synlett, 2008, 2326–2330 CAS; (b) L. Bonami, W. van Camp, D. van Rijckegem and F. E. Du Prez, Macromol. Rapid Commun., 2009, 30, 34–38 CrossRef CAS PubMed; (c) H. Hagiwara, H. Sasaki, T. Hoshi and T. Suzuki, Synlett, 2009, 643–647 CrossRef CAS PubMed; (d) Y. Wang, J. Liu and C. Xia, Adv. Synth. Catal., 2011, 353, 1534–1542 CrossRef CAS; (e) M. Liu and O. Reiser, Org. Lett., 2011, 13, 1102–1105 CrossRef CAS PubMed; (f) B. Kaboudin, Y. Abedi and T. Yokomatsu, Org. Biomol. Chem., 2012, 10, 4543–4548 RSC; (g) A. Kumar, S. Aerry, A. Saxena, A. de and S. Mozumdar, Green Chem., 2012, 14, 1298–1301 RSC; (h) Y. M. A. Yamada, S. M. Sarkar and Y. Ouzumi, J. Am. Chem. Soc., 2012, 134, 9285–9290 CrossRef CAS PubMed.
  12. (a) S. Chassaing, M. Kumarraja, A. S. S. Sido, P. Pale and J. Sommer, Org. Lett., 2007, 9, 883–886 CrossRef CAS PubMed; (b) S. Chassaing, A. S. S. Sido, A. Alix, M. Kumarraja, P. Pale and J. Sommer, Chem.–Eur. J., 2008, 14, 6713–6721 CrossRef CAS PubMed; (c) K. Namitharan, M. Kumarraja and K. Pitchumani, Chem.–Eur. J., 2009, 15, 2755–2758 CrossRef CAS PubMed; (d) P. Veerkumar, M. Velayudham, K.-L. Lu and S. Rajogopal, Catal. Sci. Technol., 2011, 1, 1512–1525 RSC; (e) J. C. Park, A. Y. Kim, J. Y. Kim, S. Park, K. H. Park and H. Song, Chem. Commun., 2012, 48, 8484–8486 RSC; (f) M. N. S. Rad, S. Behrouz, M. M. Doroodmand and A. Movahediyan, Tetrahedron, 2012, 68, 7812–7821 CrossRef PubMed; (g) S. Mohammed, A. K. Padala, B. A. Dar, B. Singh, B. Sreedhar, R. A. Vishwakarma and S. B. Bharate, Tetrahedron, 2012, 68, 8156–8162 CrossRef CAS PubMed; (h) L. Wan and C. Cai, Catal. Lett., 2012, 142, 1134–1140 CrossRef CAS; (i) J.-M. Collinson, J. D. E. T. Wilton-Ely and S. Dïez-González, Chem. Commun., 2013, 49, 11358–11360 RSC.
  13. (a) S. Kovács, K. Zih-Perényi, Á. Révész and Z. Novák, Synthesis, 2012, 44, 3722–3730 CrossRef PubMed; (b) R. Hudson, C.-J. Li and A. Moores, Green Chem., 2012, 14, 622–624 RSC.
  14. B. S. P. A. Kumar, H. V. Reddy, B. Madhav, K. Ramesh and Y. V. D. Nageswar, Tetrahedron Lett., 2012, 53, 4595–4599 CrossRef PubMed.
  15. (a) A. Megía-Fernández, M. Ortega-Muñoz, J. López-Jaramillo, F. Hernández-Mateo and F. Santoyo-González, Adv. Synth. Catal., 2010, 352, 3306–3320 CrossRef; (b) R. B. N. Baig and R. S. Varma, Green Chem., 2012, 14, 625–632 RSC.
  16. (a) A. K. Feldman, B. Colasson and V. V. Fokin, Org. Lett., 2004, 6, 3897–3899 CrossRef CAS PubMed; (b) P. Appukkuttan, W. Dehaen, V. F. Fokin and E. van der Eycken, Org. Lett., 2004, 6, 4223–4225 CrossRef CAS PubMed; (c) Z.-X. Wang and Z.-G. Zhao, J. Heterocycl. Chem., 2007, 44, 89–92 CrossRef CAS; (d) J. T. Fletcher and J. E. Reilly, Tetrahedron Lett., 2011, 52, 5512–5515 CrossRef CAS PubMed; (e) R. B. N. Baig and R. S. Varma, Chem. Commun., 2012, 48, 5853–5855 RSC; (f) S. Koguchi and K. Izawa, Synthesis, 2012, 44, 3603–3608 CrossRef CAS PubMed.
  17. (a) R. Cano, D. J. Ramón and M. Yus, Tetrahedron, 2011, 67, 5432–5436 CrossRef CAS PubMed; (b) R. Cano, D. J. Ramón and M. Yus, J. Org. Chem., 2011, 76, 5547–5557 CrossRef CAS PubMed; (c) R. Cano, M. Yus and D. J. Ramón, Tetrahedron, 2011, 67, 8079–8085 CrossRef CAS PubMed; (d) R. Cano, M. Yus and D. J. Ramón, ACS Catal., 2012, 2, 1070–1078 CrossRef CAS; (e) R. Cano, M. Yus and D. J. Ramón, Chem. Commun., 2012, 48, 7628–7630 RSC.
  18. (a) R. Martínez, D. J. Ramón and M. Yus, Adv. Synth. Catal., 2008, 350, 1235–1240 CrossRef; (b) R. Martínez, D. J. Ramón and M. Yus, Org. Biomol. Chem., 2009, 7, 2176–2181 RSC; (c) R. Cano, M. Yus and D. J. Ramón, Synlett, 2011, 2017–2020 CAS.
  19. (a) M. J. Aliaga, D. J. Ramón and M. Yus, Org. Biomol. Chem., 2010, 8, 43–46 RSC; (b) R. Cano, D. J. Ramón and M. Yus, J. Org. Chem., 2010, 75, 3458–3460 CrossRef CAS PubMed; (c) R. Cano, M. Yus and D. J. Ramón, Tetrahedron, 2012, 68, 1393–1400 CrossRef CAS PubMed; (d) J. M. Pérez, R. Cano, M. Yus and D. J. Ramón, Eur. J. Org. Chem., 2012, 4548–4554 CrossRef; (e) J. M. Pérez, R. Cano, M. Yus and D. J. Ramón, Synthesis, 2013, 45, 1373–1379 CrossRef PubMed.
  20. (a) B. H. Lipshutz, D. M. Nihan, E. Vinogradova, B. R. Taft and Ž. V. Bošković, Org. Lett., 2008, 10, 4279–4282 CrossRef CAS PubMed; (b) J. Gong, J. Liu, L. M. Ma, X. Wen, X. Chen, D. Wan, H. Yu, Z. Jiang, E. Borowiak-Palen and T. Tang, Appl. Catal., B, 2012, 117–118, 185–193 CrossRef CAS PubMed.
  21. J. Albdadi, M. Keshavarz, M. Abedini and M. Vafaie-nezhad, Chin. Chem. Lett., 2012, 23, 797–800 CrossRef PubMed.
  22. X. Meng, X. Xu, T. Gao and B. Chen, Eur. J. Org. Chem., 2010, 5409–5414 CrossRef CAS.
  23. D.-R. Hou, T.-C. Kuan, Y.-K. Li, R. Lee and K.-W. Huang, Tetrahedron, 2010, 66, 9415–9420 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Particle size distribution for catalysts, XPS Data and TEM images of new Ni–Cu–Fe3O4 catalyst, as well as copies of 1H and 13C-NMR for all compounds 3, 9, 11 and 12. See DOI: 10.1039/c4ra03149k

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.